LoginRegister

    Marksans Pharma gets EIR from USFDA for its Goa facility

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    Marksans Pharma gets EIR from USFDA for its Goa facility

    New Delhi: Drug firm Marksans Pharma Thursday said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.


    The company has received EIR from the United States Food and Drug Administration (USFDA) in respect of inspection of its Goa facility carried out from February 25 to March 6, 2019, Marksans Pharma said in a filing to the BSE.


    The Mumbai-headquartered firm is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets.

    Read Also: Marksans Pharma gets 8 USFDA observations for its Goa facility

    Shares of Marksans Pharma Thursday ended at Rs 22.70 per scrip on the BSE, up 3.89 per cent from its previous close.
    BSEDrug firm Marksans PharmaEIREstablishment Inspection Reportgeneric pharmaceuticalGoa facilityMarksans PharmaNew DelhiShares of Marksans PharmaUnited States Food and Drug AdministrationUS healthUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X